Drug Discovery Services Market by Process, Type, Drug Type, Therapeutic Area, End-user and Region - Global Forecast to 2026
February 21, 2022 07:13 ET
|
Research and Markets
Dublin, Feb. 21, 2022 (GLOBE NEWSWIRE) -- The "Drug Discovery Services Market by Process (Target Selection, Validation, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small molecules,...
Faro Health Inc. Expands Leadership Team and Announces Participation at SCOPE, Following Its $15 Million Series A Funding
February 03, 2022 05:00 ET
|
Faro Health Inc
LA JOLLA, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Faro Health, the clinical protocol solutions company, today announced that it has strengthened its leadership team with the appointment of...
Lui Franciosi Launches New Consultancy Website to Support Pharmaceutical Discovery and Development
January 06, 2022 16:00 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new consultancy website, Franciosi Consulting Ltd. to offer support and guidance...
Lui Franciosi To Monitor the Safety and Efficacy of Nebulized Heparin for the Treatment of COVID-19
January 06, 2022 12:00 ET
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi will be monitoring the safety and efficacy of nebulized heparin for the treatment of SARS-CoV-2, i.e., COVID-19. There is...
Outlook on the TIGIT Inhibitor Industry 2022 - Key Drivers and Challenges
December 21, 2021 04:53 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Global TIGIT Inhibitor Drug Opportunity & Clinical Research Insight 2022" report has been added to ResearchAndMarkets.com's offering. T-cell...
Global TROP2 Antibody Market & Clinical Trials Report 2021-2026 - Ongoing Clinical Trials Assessment by Status, Phase & Region
December 21, 2021 04:08 ET
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The global Trop2...
Worldwide Site Management Organizations Industry to 2035 - Featuring 23andMe, Ace Research and Antev Among Others
December 16, 2021 07:43 ET
|
Research and Markets
Dublin, Dec. 16, 2021 (GLOBE NEWSWIRE) -- The "Site Management Organizations Market by Therapeutic Areas, Trial Phases, Clinical Trial Components, Type of Interventions and Key Geographies: Industry...
Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate
December 16, 2021 07:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the first participant dosed in its phase 1 study, EBS-UFV-001, evaluating the safety,...
Global TRK Inhibitors Market Research Report 2021: A Highly Crowded Pipeline which Suggests a Brighter Future for TRK Inhibitors
December 06, 2021 05:43 ET
|
Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Global TRK Inhibitors Market, Drug Sales & Clinical Trials insight 2026" report has been added to ResearchAndMarkets.com's offering. The report...
Outlook on the Trispecific Antibody Global Market to 2028 - Featuring AbbVie, Biotheus and Genmab Among Others
November 22, 2021 04:13 ET
|
Research and Markets
Dublin, Nov. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibody Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The...